Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUNDTranscriptome sequencing (RNA-seq) improves diagnostic rates in individuals with suspected Mendelian conditions to varying degrees, primarily by directing the prioritization of candidate DNA variants identified on exome or genome sequencing (ES/GS). Here we implemented an RNA-seq-guided method to diagnose individuals across a wide range of ages and clinical phenotypes.METHODSOne hundred fifteen undiagnosed adult and pediatric patients with diverse phenotypes and 67 family members (182 total individuals) underwent RNA-seq from whole blood and skin fibroblasts at the Baylor College of Medicine (BCM) Undiagnosed Diseases Network clinical site from 2014 to 2020. We implemented a workflow to detect outliers in gene expression and splicing for cases that remained undiagnosed despite standard genomic and transcriptomic analysis.RESULTSThe transcriptome-directed approach resulted in a diagnostic rate of 12% across the entire cohort, or 17% after excluding cases solved on ES/GS alone. Newly diagnosed conditions included Koolen-de Vries syndrome (KANSL1), Renpenning syndrome (PQBP1), TBCK-associated encephalopathy, NSD2- and CLTC-related intellectual disability, and others, all with negative conventional genomic testing, including ES and chromosomal microarray (CMA). Skin fibroblasts exhibited higher and more consistent expression of clinically relevant genes than whole blood. In solved cases with RNA-seq from both tissues, the causative defect was missed in blood in half the cases but none from fibroblasts.CONCLUSIONSFor our cohort of undiagnosed individuals with suspected Mendelian conditions, transcriptome-directed genomic analysis facilitated diagnoses, primarily through the identification of variants missed on ES and CMA.TRIAL REGISTRATIONNot applicable.FUNDINGNIH Common Fund, BCM Intellectual and Developmental Disabilities Research Center, Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 2×
“Furthermore, interpretation guidelines set by the American College of Medical Genetics and Genomics (ACMG) apply mainly to coding changes (33), making interpreting noncoding variants found on GS challenging and serving as an opportunity for our RNA-seq–directed Figure 6.”
BackgroundMethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · cited 2×
“We quantified gene expression using RSEM (42) to generate TPM values for expressed genes in each sample.”
MethodThe mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434 · cited 1×
“To facilitate the identification of clinically relevant aberrations, we developed custom Perl scripts to annotate the DROP output with information such as OMIM disease gene status (46), gnomAD lossof-function intolerant (pLI) scores (47), DOMINO probabilities of causing dominant disease (48), ClinGen haploinsufficienc…”
MethodShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Predicting splicing from primary sequence with deep learning
Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J. F., Darbandi, S. F., Knowles, D., Li, Y. I., Kosmicki, J. A., Arbelaez, J., Cui, W., Schwartz, G. B., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.015 · Cited by 2,853
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F., & Hamosh, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1205 · Cited by 2,691
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Vooren, S. V., Moreau, Y., Pettett, R. M., & Carter, N. P. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.010 · Cited by 1,990
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2019) · doi:10.1101/531210 · Cited by 1,662
GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015) · Human Mutation · doi:10.1002/humu.22844 · Cited by 1,529 · cited 2×
“Sobreira N, et al. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.”
MethodRNA virus interference via CRISPR/Cas13a system in plants
Aman, R., Ali, Z., Butt, H., Mahas, A., Aljedaani, F., Khan, M. Z., Ding, S., & Mahfouz, M. (2018) · Genome Biology · doi:10.1186/s13059-017-1381-1 · Cited by 1,497
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496 · cited 1×
“To facilitate the identification of clinically relevant aberrations, we developed custom Perl scripts to annotate the DROP output with information such as OMIM disease gene status (46), gnomAD lossof-function intolerant (pLI) scores (47), DOMINO probabilities of causing dominant disease (48), ClinGen haploinsufficienc…”
MethodMolecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360
Self-citationGeneHancer: genome-wide integration of enhancers and target genes in GeneCards
Fishilevich, S., Nudel, R., Rappaport, N., Hadar, R., Plaschkes, I., Iny Stein, T., Rosen, N., Kohn, A., Twik, M., Safran, M., et al. (2017) · Database · doi:10.1093/database/bax028 · Cited by 1,271 · cited 1×
“The deletion encompassed all of NSD2 exon 1 (representing >80% of the 5′UTR), including the transcription start site and the upstream region containing the promoter and enhancer elements (31).”
BackgroundVariant Review with the Integrative Genomics Viewer
Robinson, J. T., Thorvaldsdóttir, H., Wenger, A. M., Zehir, A., & Mesirov, J. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0337 · Cited by 1,115 · cited 1×
“Splicing and expression abnormalities were validated by visual inspection of the RNA-seq alignment in the Integrative Genomics Viewer (IGV) (12).”
MethodImproving genetic diagnosis in Mendelian disease with transcriptome sequencing
Cummings, B. B., Marshall, J. L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A. R., Bolduc, V., Waddell, L. B., Sandaradura, S. A., O’Grady, G. L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal5209 · Cited by 831 · cited 1×
“who achieved a diagnostic rate of around 35% in patients with neuromuscular disorders using mainly muscle tissue (4, 6), Fresard et al.”
BackgroundGenetic diagnosis of Mendelian disorders via RNA sequencing
Kremer, L. S., Bader, D. M., Mertes, C., Kopajtich, R., Pichler, G., Iuso, A., Haack, T. B., Graf, E., Schwarzmayr, T., Terrile, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15824 · Cited by 590 · cited 1×
“who diagnosed 10% of patients with mitochondrial dysfunction using skin fibroblasts (5).”
BackgroundSelf-citationA new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism
Koolen, D. A., Vissers, L. E. L. M., Pfundt, R., de Leeuw, N., Knight, S. J., Regan, R., Kooy, R. F., Reyniers, E., Romano, C., Fichera, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1853 · Cited by 460 · cited 11×
“Ultimately, GS may overcome CMA coverage limitations, although costs continue to prohibit broad adoption, and mapping short reads in complex regions remains a major challenge (e.g., KANSL1 case).”
BackgroundInfluentialSouth, S. T., Lee, C., Lamb, A. N., Higgins, A. W., & Kearney, H. M. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.129 · Cited by 371
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease
Splinter, K., Adams, D. R., Bacino, C. A., Bellen, H. J., Bernstein, J. A., Cheatle-Jarvela, A. M., Eng, C. M., Esteves, C., Gahl, W. A., Hamid, R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714458 · Cited by 359 · cited 1×
“The UDN has incorporated state-of-the-art testing, including ES and genome sequencing (GS), chromosomal microarray (CMA), metabolomics, model organism screening, and inpatient evaluations, with an overall diagnostic yield of 35% (3).”
BackgroundSelf-citationIdentification of rare-disease genes using blood transcriptome sequencing and large control cohorts
Undiagnosed Diseases Network, Frésard, L., Care4Rare Canada Consortium, Smail, C., Ferraro, N. M., Teran, N. A., Li, X., Smith, K. S., Bonner, D., Kernohan, K. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0457-8 · Cited by 321 · cited 1×
“5% of undiagnosed cases from whole blood (7), and Kremer et al.”
BackgroundThe Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263 · cited 3×
“To facilitate the identification of clinically relevant aberrations, we developed custom Perl scripts to annotate the DROP output with information such as OMIM disease gene status (46), gnomAD lossof-function intolerant (pLI) scores (47), DOMINO probabilities of causing dominant disease (48), ClinGen haploinsufficienc…”
MethodMolecular diagnostic experience of whole-exome sequencing in adult patients
Posey, J. E., Rosenfeld, J. A., James, R. A., Bainbridge, M., Niu, Z., Wang, X., Dhar, S., Wiszniewski, W., Akdemir, Z. H. C., Gambin, T., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.142 · Cited by 242 · cited 1×
“Nevertheless, many patients undergoing clinical ES remain undiagnosed, and studies generally report diagnostic rates of 25%–30% (1, 2).”
BackgroundSelf-citationAutosomal recessive Noonan syndrome associated with biallelic LZTR1 variants
Johnston, J. J., van der Smagt, J. J., Rosenfeld, J. A., Pagnamenta, A. T., Alswaid, A., Baker, E. H., Blair, E., Borck, G., Brinkmann, J., Craigen, W., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.249 · Cited by 226
Self-citationDiagnostic utility of transcriptome sequencing for rare Mendelian diseases
Lee, H., Huang, A. Y., Wang, L.-K., Yoon, A. J., Renteria, G., Eskin, A., Signer, R. H., Dorrani, N., Nieves-Rodriguez, S., Wan, J., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-019-0672-1 · Cited by 224 · cited 1×
“recently used a traditional, candidate genomic variant approach to diagnose subjects enrolled in the UDN with a variety of phenotypes using multiple tissue types (whole blood, skin [fibroblasts], muscle) (8).”
MethodOUTRIDER: A Statistical Method for Detecting Aberrantly Expressed Genes in RNA Sequencing Data
Brechtmann, F., Mertes, C., Matusevičiūtė, A., Yépez, V. A., Avsec, Ž., Herzog, M., Bader, D. M., Prokisch, H., & Gagneur, J. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.025 · Cited by 220
Self-citationExpanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease
Gonorazky, H. D., Naumenko, S., Ramani, A. K., Nelakuditi, V., Mashouri, P., Wang, P., Kao, D., Ohri, K., Viththiyapaskaran, S., Tarnopolsky, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.04.004 · Cited by 204
Study, D., Koolen, D. A., Pfundt, R., Linda, K., Beunders, G., Veenstra-Knol, H. E., Conta, J. H., Fortuna, A. M., Gillessen-Kaesbach, G., Dugan, S., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.178 · Cited by 185
Wai, H. A., Lord, J., Lyon, M., Gunning, A., Kelly, H., Cibin, P., Seaby, E. G., Spiers-Fitzgerald, K., Lye, J., Ellard, S., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0766-9 · Cited by 177 · cited 5×
“In contrast, the challenge with GS is interpreting the tremendous number of VUS identified, primarily in noncoding regions.”
BackgroundInfluentialDetection of aberrant splicing events in RNA-seq data using FRASER
Mertes, C., Scheller, I. F., Yépez, V. A., Çelik, M. H., Liang, Y., Kremer, L. S., Gusic, M., Prokisch, H., & Gagneur, J. (2021) · Nature Communications · doi:10.1038/s41467-020-20573-7 · Cited by 176
Self-citationAlfares, A., Aloraini, T., subaie, L. A., Alissa, A., Qudsi, A. A., Alahmad, A., Mutairi, F. A., Alswaid, A., Alothaim, A., Eyaid, W., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.41 · Cited by 175 · cited 1×
“This issue is likely a significant deterrent to the broader application of GS and contributes to the relatively modest improvement in diagnostic rate with GS alone, which one recent study showed being only 7% higher than ES (32).”
ResultMutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation
Kalscheuer, V. M., Freude, K., Musante, L., Jensen, L. R., Yntema, H. G., Gécz, J., Sefiani, A., Hoffmann, K., Moser, B., Haas, S., et al. (2003) · Nature Genetics · doi:10.1038/ng1264 · Cited by 172 · cited 1×
“Most of the causative PQBP1 variants are exonic frameshift deletions leading to markedly reduced gene expression via nonsense-mediated mRNA decay (NMD) and impaired protein function (17, 18).”
BackgroundDetection of aberrant gene expression events in RNA sequencing data
Yépez, V. A., Mertes, C., Müller, M. F., Klaproth-Andrade, D., Wachutka, L., Frésard, L., Gusic, M., Scheller, I. F., Goldberg, P. F., Prokisch, H., et al. (2021) · Nature Protocols · doi:10.1038/s41596-020-00462-5 · Cited by 165
Self-citationRetterer, K., Scuffins, J., Schmidt, D., Lewis, R., Pineda-Alvarez, D., Stafford, A., Schmidt, L., Warren, S., Gibellini, F., Kondakova, A., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.160 · Cited by 139 · cited 1×
“Although ES may also detect some larger CNVs, especially those 3 exons or larger (36), none of the causative deletions in the above cases were reported by ES, as current pipelines to identify CNVs still suffer from batch-to-batch variation (37).”
BackgroundDOMINO: Using Machine Learning to Predict Genes Associated with Dominant Disorders
Quinodoz, M., Royer‐Bertrand, B., Cisarova, K. V., Gioia, S. A. D., Superti‐Furga, A., & Rivolta, C. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.001 · Cited by 138 · cited 1×
“To facilitate the identification of clinically relevant aberrations, we developed custom Perl scripts to annotate the DROP output with information such as OMIM disease gene status (46), gnomAD lossof-function intolerant (pLI) scores (47), DOMINO probabilities of causing dominant disease (48), ClinGen haploinsufficienc…”
MethodAicher, J. K., Jewell, P., Vaquero-Garcia, J., Barash, Y., & Bhoj, E. J. K. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0780-y · Cited by 102 · cited 9×
“Although more invasive to obtain and subsequent processing was needed, we felt the improved consistency and number of well-expressed (TPM > 10) genes in fibroblasts associated with common proband phenotypes justified the additional effort.”
BackgroundMethodInfluentialLenski, C., Abidi, F., Meindl, A., Gibson, A., Platzer, M., Kooy, R. F., Lubs, H. A., Stevenson, R. E., Ramser, J., & Schwartz, C. E. (2004) · The American Journal of Human Genetics · doi:10.1086/383205 · Cited by 93 · cited 1×
“Defects in PQBP1 cause Renpenning syndrome (MIM 309500), an X-linked ID syndrome characterized by males with microcephaly, short stature, cardiac and renal anomalies, small testes, and dysmorphic features (15).”
BackgroundCODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing
Jiang, Y., Wang, R., Urrutia, E., Anastopoulos, I. N., Nathanson, K. L., & Zhang, N. R. (2018) · Genome biology · doi:10.1186/s13059-018-1578-y · Cited by 83 · cited 1×
“Although ES may also detect some larger CNVs, especially those 3 exons or larger (36), none of the causative deletions in the above cases were reported by ES, as current pipelines to identify CNVs still suffer from batch-to-batch variation (37).”
BackgroundAssessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer
Karam, R., Conner, B. R., LaDuca, H., McGoldrick, K., Krempely, K. E., Richardson, M. E., Zimmermann, H., Gutierrez, S., Reineke, P., Hoang, L., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13900 · Cited by 80 · cited 3×
“Transcriptome sequencing (RNA-seq) is emerging as another tool in the genetic diagnostic toolbox, leading to a reported 7.5%– 36% improvement in the diagnostic rate depending on the sampled tissue and clinical phenotype (4–8), and aiding in the prioritization and resolution of variants of uncertain significance (VUS)…”
BackgroundInfluentialMoles‐Fernández, A., Duran-Lozano, L., Montalban, G., Bonache, S., López‐Perolio, I., Menéndez, M., Santamariña, M., Behar, R., Blanco, A., Carrasco, E., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00366 · Cited by 72
The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1-mutated males
Germanaud, D., Rossi, M., Bussy, G., Gérard, D., Hertz‐Pannier, L., Blanchet, P., Dollfus, H., Giuliano, F., Greene, V. B., Sardá, P., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01551.x · Cited by 59 · cited 1×
“Most of the causative PQBP1 variants are exonic frameshift deletions leading to markedly reduced gene expression via nonsense-mediated mRNA decay (NMD) and impaired protein function (17, 18).”
BackgroundDevelopmental delay and failure to thrive associated with a loss‐of‐function variant in WHSC1 (NSD2)
Boczek, N. J., Lahner, C. A., Nguyen, T., Ferber, M. J., Hasadsri, L., Thorland, E. C., Niu, Z., & Gavrilova, R. H. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40498 · Cited by 54
Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project
Machini, K., Ceyhan‐Birsoy, O., Azzariti, D. R., Sharma, H., Rossetti, P., Mahanta, L., Hutchinson, L., McLaughlin, H. M., Green, R. C., Lebo, M. S., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.017 · Cited by 52 · cited 1×
“In one recent report, the time required was up to 6–8 hours for genome analysis (14).”
BackgroundMKinfer: Inferential Statistics
Kohl, M. (2019) · doi:10.32614/cran.package.mkinfer · Cited by 51
CLTC as a clinically novel gene associated with multiple malformations and developmental delay
DeMari, J., Mroske, C., Tang, S., Nimeh, J., Miller, R., & Lebel, R. R. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37506 · Cited by 50 · cited 2×
“Defects in CLTC are associated with an autosomal dominant disorder (MIM 617854) with a variable phenotype that includes ID, developmental delay (DD), and epilepsy (20, 21).”
BackgroundTucker, T., Zahir, F., Griffith, M., Delaney, A. D., Chai, D., Tsang, E. S., Lemyre, E., Dobrzeniecka, S., Marra, M. A., Eydoux, P., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.248 · Cited by 44 · cited 1×
“The ACMG recommends that CMA designs allow detection of gains or losses of 400 kb or larger (34), and some modern CMA platforms offer single-exon resolution of clinically relevant genes (35).”
MethodDerar, N., Al‐Hassnan, Z. N., Al‐Owain, M. A., Monies, D., Abouelhoda, M. I., Meyer, B. F., Moghrabi, N. N., & Alkuraya, F. S. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0014-8 · Cited by 36
Sá, M. J. N., Venselaar, H., Wiel, L., Trimouille, A., Lasseaux, E., Naudion, S., Lacombe, D., Piton, A., Vincent‐Delorme, C., Zweier, C., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0703-y · Cited by 35 · cited 2×
“Defects in CLTC are associated with an autosomal dominant disorder (MIM 617854) with a variable phenotype that includes ID, developmental delay (DD), and epilepsy (20, 21).”
BackgroundResultWan, D., Zhang, Z. C., Zhang, X., Li, Q., & Han, J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv191 · Cited by 25 · cited 1×
“The encoded polyglutamine-binding protein 1 has been shown to have an essential role in neurodevelopment (16).”
BackgroundInfantile-Onset Multisystem Neurologic, Endocrine, and Pancreatic Disease: Case and Review
Le, C., Prasad, A. N., Rupar, C. A., Debicki, D., Andrade, A., & Prasad, C. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.35 · Cited by 20 · cited 3×
“Genome sequencing revealed a heterozygous 22.7 kb deletion (chr17: 57756685–57779426) that removed the segment from exon 18 to the transcription end of CLTC and part of the adjacent PTRH2 (Figure 5B), consistent with a diagnosis of CLTC-associated ID. Polymerase chain reaction (PCR) analysis (Figure 5C) confirmed the…”
BackgroundInfluential
Cited by
The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics
Zhao, S., Sinson, J. C., Li, S., Rosenfeld, J. A., Zapata, G., Macakova, K., Pena, M., Maywald, B., Worley, K. C., Burrage, L. C., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.09.013 · Cited by 5
Self-citation
Metadata
- Authors
- Murdock, D. R., Dai, H., Burrage, L. C., Rosenfeld, J. A., Ketkar, S., Müller, M. F., Yépez, V. A., Gagneur, J., Liu, P., Chen, S., Jain, M., Zapata, G., Bacino, C. A., Chao, H.-T., Moretti, P., Craigen, W. J., Hanchard, N. A., & Lee, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W3091027401
- Cited by
- 185
- References
- 52
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.